Literature DB >> 22163360

Clinical inquiry: What treatment is best for hypertrophic scars and keloids?

Carol C Williams1, Sandy De Groote.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22163360

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


× No keyword cloud information.
  4 in total

Review 1.  The role of fibrosis in Duchenne muscular dystrophy.

Authors:  Werner Klingler; Karin Jurkat-Rott; Frank Lehmann-Horn; Robert Schleip
Journal:  Acta Myol       Date:  2012-12

2.  In vivo early intervention and the therapeutic effects of 20(s)-ginsenoside rg3 on hypertrophic scar formation.

Authors:  Liying Cheng; Xiaoming Sun; Changmin Hu; Rong Jin; Baoshan Sun; Yaoming Shi; Wenguo Cui; Yuguang Zhang
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

3.  Lower energy radial shock wave therapy improves characteristics of hypertrophic scar in a rabbit ear model.

Authors:  Jing-Chun Zhao; Bo-Ru Zhang; Kai Shi; Jian Wang; Qing-Hua Yu; Jia-Ao Yu
Journal:  Exp Ther Med       Date:  2017-11-06       Impact factor: 2.447

4.  Extracorporeal shock wave therapy with low-energy flux density inhibits hypertrophic scar formation in an animal model.

Authors:  Jing-Chun Zhao; Bo-Ru Zhang; Lei Hong; Kai Shi; Wei-Wei Wu; Jia-Ao Yu
Journal:  Int J Mol Med       Date:  2018-01-29       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.